Edition:
India

Biogaia AB (BIOGb.ST)

BIOGb.ST on Stockholm Stock Exchange

321.50SEK
19 Jan 2018
Change (% chg)

3.00kr (+0.94%)
Prev Close
318.50kr
Open
319.00kr
Day's High
324.00kr
Day's Low
318.00kr
Volume
23,226
Avg. Vol
17,371
52-wk High
369.50kr
52-wk Low
278.50kr

Chart for

About

Biogaia AB is a Sweden-based company engaged in the development and sell of probiotic products, primarily based on the Lactobacillus reuteri bacteria. The Company’s activities are divided into three segments: Finished consumer products, which distributes tablets, drops, Oral Rehydration Solutions (ORSs), and oral health... (more)

Overall

Beta: 0.84
Market Cap(Mil.): kr4,987.04
Shares Outstanding(Mil.): 16.60
Dividend: 3.16
Yield (%): 2.50

Financials

  Industry Sector
P/E (TTM): -- 22.59 16.58
EPS (TTM): -- -- --
ROI: -- 12.23 10.60
ROE: -- 15.61 14.19

BRIEF-Biogaia signs deal with Abbott to launch probiotic in China

* SAYS HAS SIGNED AN EXCLUSIVE AGREEMENT WITH ABBOTT FOR RIGHTS TO COMMERCIALIZE BIOGAIA PROTECTIS TABS IN CHINA

18 Jan 2018

BRIEF-Biogaia Q3 operating profit up 11 pct​

* Biogaia says Q3 ‍net sales amounted to 147.7 million SEK(126.0), up 17 pct​

25 Oct 2017

BRIEF-BioGaia Q2 op profit rose to SEK 60 mln

* Q2 net sales amounted to SEK 156.0 million (136.0), an increase of 15% (excluding foreign exchange effects, 10%).

18 Aug 2017

Earnings vs. Estimates